Experience of gene therapy in the United Kingdom

Annals of the New York Academy of Sciences

Volumn 862, Issue , 1998, Pages 184-187

  Nevin, Norman C ^a  

^a ROYAL GROUP OF HOSPITALS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COMPETENCE; CONFERENCE PAPER; EXPERT SYSTEM; GENE THERAPY; GOVERNMENT; HEALTH; HUMAN; MEDICAL ETHICS; MEDICAL RESEARCH; NONHUMAN; PROFESSIONAL STANDARD; SAFETY; UNITED KINGDOM; XENOTRANSPLANTATION;

EID: 0032437438     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1998.tb09134.x     Document Type: Conference Paper

References (6)

1. 1. Report on the Committee on the Ethics of Gene Therapy, January 1992.: 1-41. HMSO. London.
2. 2. Third Annual Report: January 1996-December 1996, Gene Therapy Advisory Committee, Health Departments of the United Kingdom, London, June 1997.: 1-20.
3. 3. 1995. Gene Therapy Advisory Committee Guidance on Making Proposals to Conduct Gene Therapy Research on Human Subjects. Department of Health, United Kingdom.
4. 4. Science and Technology Committee. 1995. Third Report on Human Genetics: The Science and Its Consequences. HMSO. London.
5. 5. Ledley, F.D., B. Brody, C.A. Kozinetz & S.G. Mize. 1992. The challenge of follow-up for clinical trials of somatic gene therapy. Hum. Gene Ther. 3: 657-663.
6. 6. First Annual Report: November 1993-December 1994, Health Departments of the United Kingdom, London, March 1995.: 1-21.